DIAGNOS Inc. (OTCMKTS:DGNOF – Get Free Report)’s stock price traded up 5.4% during mid-day trading on Tuesday. The company traded as high as $0.2588 and last traded at $0.2587. Approximately 48,500 shares traded hands during mid-day trading, The stock had previously closed at $0.2454.
DIAGNOS Stock Performance
The company has a debt-to-equity ratio of 0.33, a current ratio of 1.49 and a quick ratio of 1.49. The stock has a market cap of $31.57 million, a P/E ratio of -6.43 and a beta of 0.01. The company has a fifty day moving average price of $0.32 and a 200 day moving average price of $0.22.
DIAGNOS Company Profile
DIAGNOS Inc is a Canadian healthcare technology company that develops artificial intelligence and data-analysis solutions for the early detection of diseases. Its principal platform, CARA, is designed to analyze retinal images and assist healthcare professionals in screening for diabetic retinopathy and other eye-related conditions.
The company’s technology is intended to support screening programs in settings such as primary-care offices, pharmacies, clinics and community health facilities.
Further Reading
- Five stocks we like better than DIAGNOS
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.
